Raquel Hladun Alvaro

Institutions of which they are part

Predoctoral researcher
Childhood Cancer and Blood Disorders

Vall Hebron Institut de Recerca

Institutions of which they are part

Predoctoral researcher
Childhood Cancer and Blood Disorders

Vall Hebron Institut de Recerca

Projects

Next generation personalised medicine for childhood cancers

IP: Lucas Moreno Martín-Retortillo
Collaborators: Aroa Soriano Fernández, Jessica Camacho Soriano, Raquel Hladun Alvaro, Gabriela Guillén Burrieza, Andrea Vilaplana Blanes, Lorena Valero Arrese, Sergio Manresa Vera, Mariona Morell Daniel
Funding agency: Instituto de Salud Carlos III
Funding: 214170
Reference: PI21/01661
Duration: 01/01/2022 - 31/12/2024

Nuevas estrategias de inhibición de la vía Hedgehog como dianas terapéuticas en el rabdominosarcoma.

IP: Josep Roma Castanyer
Collaborators: Josep Sánchez de Toledo Codina, Anna Llort Sales, Raquel Hladun Alvaro, Patricia Zarzosa Martinez
Funding agency: Instituto de Salud Carlos III
Funding: 87120
Reference: PI18/00398
Duration: 01/01/2019 - 31/12/2021

Investigació translacional en càncer infantil (GRE)

IP: Josep Sánchez de Toledo Codina
Collaborators: Aroa Soriano Fernández, Maria Cristina Díaz de Heredia Rubio, Miguel Segura Ginard, Anna Llort Sales, Raquel Hladun Alvaro, Investigació translacional en càncer infantil (GRE) , Laura Alonso Garcia, Josep Roma Castanyer
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 30000
Reference: 2014 SGR 660
Duration: 01/01/2014 - 31/12/2016

Phase I/II Gene Therapy Trial of Fanconi anemia patients with a new Orphan Drug consisting of a lentiviral vector carrying the FANCA gene: A Coordinated International Action (EUROFANCOLEN) Grant Agreement nº 305421

IP: Josep Sánchez de Toledo Codina
Collaborators: Jordi Barquinero Mañez, Maria Cristina Díaz de Heredia Rubio, Raquel Hladun Alvaro
Funding agency: EUROPEAN COMMISSION
Funding: 285000
Reference: EUROFANCOLEN_FP7HEALTH2012
Duration: 01/01/2013 - 31/12/2018